A SNHG5/miR‐205‐5p/ZEB1 signaling axis was presented to uncover the underlying mechanism of tumorigenesis and progression in ccRCC; this axis also offers potential therapeutic targets against ccRCC. This evidence concerns the gene ZEB1 and nonpapillary renal cell carcinoma.